Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diocare Dual IgG and IgA Respiratory Immunity is a proprietary oral capsule product in the Diocare line developed by Diomics Corporation in partnership with Bonne Santé Group and introduced in 2021 in the context of the COVID-19 pandemic. Based on the available information, it appears to be a natural health product or dietary supplement marketed for support of respiratory immune function, with positioning around enhancement of IgG- and IgA-associated immunity rather than a defined pharmaceutical mechanism directed at a validated molecular target. The product was associated with Bonne Santé's natural manufacturing operations and appears to have been developed, launched, and distributed under a strategic alliance rather than through conventional drug-development pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Diocare Dual IgG and IgA Respiratory Immunity.